KUHLA DONALD E 4
4 · NPS PHARMACEUTICALS INC · Filed Jan 20, 2009
Insider Transaction Report
Form 4
KUHLA DONALD E
Director
Transactions
- Award
Deferred Stock Units
2009-01-15+3,470→ 92,605 total→ Common Stock (3,470 underlying)
Footnotes (2)
- [F1]Each Deferred Stock Unit represents a right to receive one share of NPS Common Stock.
- [F2]Deferred Stock Units awarded under the NPS Pharmaceuticals, Inc. 2007 Nonemployee Directors' Compensation Program will be settled in NPS Common Stock upon (1) separation from service on the Board, (2) death, (3) disability, or (4) sale of substantially all the assets of the Company.